Delivery Order 75N91022D00016-75N91022F00001
Award Date 9/26/22
Potential Completion Date 4/25/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas. IITRI has extensive experience providing these services to...
- The National Cancer Institute awarded a definitive cost-plus-fixed-fee contract to IIT Research Institute (IITRI), a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, for preclinical toxicology and pharmacology services supporting drug development for cancer, AIDS, and AIDS-related illnesses. The contract, awarded on April 1, 2004, carries a ceiling value of $159.3 million with an ultimate completion date of June 30, 2016, and will be performed...
- This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...
- This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...
- The National Cancer Institute awarded a $9.35 million cost-plus-fixed-fee contract to IIT Research Institute (IITRI) on April 1, 2022, for preclinical toxicology studies of large molecule drugs developed for cancer and other indications. The contract, which extends through March 31, 2029, will be performed in Chicago, Illinois. IITRI, a nonprofit contract research organization and subsidiary of Illinois Institute of Technology, will conduct comprehensive toxicological testing and safety...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...
- This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $23,349,236 contract is for the provision of preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. IITRI, which has extensive experience supporting the preclinical development of various therapeutics for federal...
- This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
- This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...
- This is a delivery order issued against the Preclinical Agent Development Assays 2012-2016 contract vehicle by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to the IIT Research Institute (IITRI), a non-profit contract research organization, to conduct other functions related to preclinical in vitro and in vivo agent development assays, including an orientation meeting. The total ceiling value of this...